Effects of Korean Red Ginseng combination therapy on HIV-infected patients treated with integrase strand transfer inhibitors
Journal of Ginseng Research · 2024-11 · 48 (6) · 603-608
DOI: 10.1016/j.jgr.2024.09.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ginseng Research, 2024-11. Verfasst von Young-Keol Cho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, University of Ulsan College of Medicine, Seoul, Republic of Korea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Korean Red Ginseng (KRG) combined with antiretroviral therapy (ART) has shown benefits in the treatment of HIV-1-infected patients. Current guidelines recommend regimens containing integrase strand transfer inhibitors (INSTIs) as first-line treatment for these patients. The present study assessed the duration of effectiveness of ginseng combination therapy (GCT) in patients receiving INSTIs.
Methods
This study included 58 HIV-1-infected patients previously untreated with monotherapy or two-drug combination therapy. Patients in the GCT (n = 26) group received ART plus KRG for 164 ± 64 months, whereas patients in the control (n = 32) group received ART alone for 128 ± 49 months. Subsequently, patients in these two groups received INSTI for 81 ± 36 months and 68 ± 26 months, respectively.
Results
Before INSTI treatment, only one drug resistance mutation (DRM) was observed in the GCT group, compared with an overall resistance rate of 44.4 % in the control group (P < 0.001). The overall resistance rate was higher in the control than in the GCT group (9.5 % vs. 0.12 %, P < 0.001). During INSTI treatment, the resistance rate in the GCT group remained 0 % for over 5 years, but gradually decreased in the control group from 18.3 % to 13.9 % over 6 years, indicating that the between-group difference in resistance rate gradually decreased during INSTI treatment.
Conclusion
The beneficial effects of KRG were well maintained for more than 20 years, including the INSTI treatment period.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Zitieren
APA
Cho, Y. K., Lee, J., Kim, J. E., & Sung, H. (2024). Effects of Korean Red Ginseng combination therapy on HIV-infected patients treated with integrase strand transfer inhibitors. Journal of Ginseng Research, 48(6), 603-608. https://doi.org/10.1016/j.jgr.2024.09.003
Vancouver
Cho YK, Lee J, Kim JE, Sung H. Effects of Korean Red Ginseng combination therapy on HIV-infected patients treated with integrase strand transfer inhibitors. Journal of Ginseng Research. 2024;48(6):603-608. doi:10.1016/j.jgr.2024.09.003
BibTeX
@article{Cho2024,
author = {Cho, Young-Keol and Lee, Jinny and Kim, Jung-Eun and Sung, Heungsup},
title = {Effects of Korean Red Ginseng combination therapy on HIV-infected patients treated with integrase strand transfer inhibitors},
journal = {Journal of Ginseng Research},
year = {2024},
volume = {48},
number = {6},
pages = {603--608},
doi = {10.1016/j.jgr.2024.09.003}
}
EUVIMED